Matthew Pauls Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew Pauls.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew Pauls. Matthew Pauls is CHIEF EXECUTIVE OFFICER in Savara Inc ($SVRA) and Director in Mast Therapeutics, Inc. ($MSTX) and See Remarks in Savara Inc ($SVRA) and Director in Egalet Corp ($EGLT) and President & CEO in Strongbridge Biopharma plc ($SBBP).
Latest Insider Trading Transactions of Matthew Pauls
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, SVRA, SBBP, EGLT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19 2021 | SVRA | Savara Inc | Pauls Matthew | CHIEF EXECUTIVE OFF ... | Buy | P | 1.82 | 27,400 | 49,871 | 308,122 | 280.7 K to 308.1 K (+9.76 %) |
| Mar 22 2021 | SVRA | Savara Inc | Pauls Matthew | CHIEF EXECUTIVE OFF ... | Buy | P | 2.07 | 24,100 | 49,938 | 280,722 | 256.6 K to 280.7 K (+9.39 %) |
| Mar 22 2021 | SVRA | Savara Inc | Pauls Matthew | CHIEF EXECUTIVE OFF ... | Buy | P | 2.07 | 24,100 | 49,938 | 280,722 | 256.6 K to 280.7 K (+9.39 %) |
| Feb 23 2021 | SVRA | Savara Inc | Pauls Matthew | CHIEF EXECUTIVE OFF ... | Buy | P | 1.74 | 28,700 | 50,038 | 256,622 | 227.9 K to 256.6 K (+12.59 %) |
| Dec 17 2020 | SVRA | Savara Inc | Pauls Matthew | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.23 | 500,000 | 615,000 | 500,000 | |
| Sep 15 2020 | SVRA | Savara Inc | Pauls Matthew | See Remarks | Option Exercise | A | 1.32 | 898,639 | 1,186,203 | 898,639 | |
| Sep 15 2020 | SVRA | Savara Inc | Pauls Matthew | See Remarks | Option Exercise | M | 0.00 | 650 | 0 | 0 | |
| Sep 15 2020 | SVRA | Savara Inc | Pauls Matthew | See Remarks | Grant | A | 0.00 | 227,272 | 0 | 227,922 | 650 to 227.9 K (+34,964.92 %) |
| Sep 15 2020 | SVRA | Savara Inc | Pauls Matthew | See Remarks | Buy | M | 0.00 | 650 | 0 | 650 | 0 to 650 |
| May 21 2020 | EGLT | Zyla Life Sciences | Pauls Matthew | Director | Sell | D | 0.00 | 26,953 | 0 | 0 | 27 K to 0 (-100.00 %) |
| Apr 24 2020 | EGLT | Zyla Life Sciences | Pauls Matthew | Director | Option Exercise | M | 0.00 | 6,667 | 0 | 13,333 | |
| Apr 24 2020 | EGLT | Zyla Life Sciences | Pauls Matthew | Director | Payment of Exercise | F | 1.75 | 952 | 1,666 | 5,715 | 6.7 K to 5.7 K (-14.28 %) |
| Apr 24 2020 | EGLT | Zyla Life Sciences | Pauls Matthew | Director | Buy | M | 1.75 | 6,667 | 11,667 | 6,667 | 0 to 6.7 K |
| Mar 05 2020 | EGLT | Zyla Life Sciences | Pauls Matthew | Director | Grant | A | 0.00 | 13,620 | 0 | 13,620 | 0 to 13.6 K |
| Dec 26 2019 | SVRA | Savara Inc | Pauls Matthew | Director | Option Exercise | A | 1.59 | 12,000 | 19,080 | 12,000 | |
| Apr 24 2019 | EGLT | Egalet Corp | Pauls Matthew | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Feb 22 2019 | SBBP | Strongbridge Bioph ... | Pauls Matthew | President & CEO | Option Exercise | A | 4.67 | 400,000 | 1,868,000 | 400,000 | |
| Feb 22 2019 | SBBP | Strongbridge Bioph ... | Pauls Matthew | President & CEO | Grant | A | 0.00 | 50,000 | 0 | 72,608 | 22.6 K to 72.6 K (+221.16 %) |
| Dec 14 2018 | SVRA | Savara Inc | Pauls Matthew | Director | Option Exercise | A | 7.33 | 12,000 | 87,960 | 12,000 | |
| Feb 28 2018 | SBBP | Strongbridge Bioph ... | Pauls Matthew | President & CEO | Payment of Exercise | F | 6.60 | 17,392 | 114,787 | 22,608 | 40 K to 22.6 K (-43.48 %) |
| Feb 06 2018 | SBBP | Strongbridge Bioph ... | Pauls Matthew | President & CEO | Option Exercise | A | 6.65 | 350,000 | 2,327,500 | 350,000 | |
| May 26 2017 | MSTX | Savara Inc | Pauls Matthew | Director | Option Exercise | A | 5.13 | 3,750 | 19,238 | 3,750 | |
| Jan 23 2017 | MSTX | Mast Therapeutics, ... | Pauls Matthew | Director | Option Exercise | A | 0.00 | 45,535 | 0 | 45,535 | |
| Jun 17 2016 | MSTX | Mast Therapeutics, ... | Pauls Matthew | Director | Option Exercise | A | 0.43 | 79,551 | 34,207 | 79,551 | |
| Nov 02 2015 | MSTX | Mast Therapeutics, ... | Pauls Matthew | Director | Option Exercise | A | 0.48 | 37,794 | 18,141 | 37,794 | |
| Nov 02 2015 | MSTX | Mast Therapeutics, ... | Pauls Matthew | Director | Option Exercise | A | 0.48 | 64,791 | 31,100 | 64,791 |
Page: 1